Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study

New Insight on the Safety of Erenumab: An Analysis of Spontaneous Reports of Adverse Events Recorded in the US Food and Drug Administration Adverse Event Reporting System Database

(2021) Maurizio Sessa et al.   BIODRUGS

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

(2021) Fabrizio Vernieri et al.   JOURNAL OF HEADACHE AND PAIN

Real-Life Response to Erenumab in a Therapy-Resistant Case Series of Migraine Patients From the Province of Québec, Eastern Canada

(2021) Marzieh Eghtesadi et al.   CLINICAL DRUG INVESTIGATION

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study

(2021) Simone de Vries Lentsch et al.   EUROPEAN JOURNAL OF NEUROLOGY

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

(2021) Jessica Ailani et al.   HEADACHE

Initial experience with novel CGRP-receptor inhibitor therapy in Migraine in the United Arab Emirates: a retrospective observational study

(2021) Bui Bao Khanh Dinh et al.   BMC Neurology

Cephalgia Alopecia

(2020) Kate O. Bedrin et al.   Current Pain and Headache Reports

Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review

(2020) Atrin Toussi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Botulinum toxin as a double‐edged sword in alopecia: a systematic review

(2020) Yuanzhuo Wang et al.   Journal of Cosmetic Dermatology

Real-world effectiveness and tolerability of erenumab: A retrospective cohort study

(2020) Saad Kanaan et al.   CEPHALALGIA

Safety and Tolerability of 3 CGRP Monoclonal Antibodies in Practice: A Retrospective Cohort Study

(2020) Ashley Alex et al.   HEADACHE

Erenumab in Chronic Migraine: An Australian Experience

(2020) Shuli Cheng et al.   HEADACHE

Bidirectional association between alopecia areata and migraine: A nationwide population-based cohort study

(2020) Ying-Xiu Dai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

All-Cause and Cause-Specific Mortality Risks Associated With Alopecia Areata

(2019) Solam Lee et al.   JAMA Dermatology

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

(2019) Michel D Ferrari et al.   LANCET

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

(2018)   CEPHALALGIA

Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2018) Lars Jacob Stovner et al.   LANCET NEUROLOGY

Blocking CGRP in migraine patients – a review of pros and cons

(2017) Marie Deen et al.   JOURNAL OF HEADACHE AND PAIN

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area

(2014) Birgitta Grundmark et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

What causes alopecia areata?

(2013) K. J. McElwee et al.   EXPERIMENTAL DERMATOLOGY

Effects of calcitonin gene-related peptide on the immune privilege of human hair follicles

(2012) Long-Quan Pi et al.   NEUROPEPTIDES

Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-γ-induced collapse of human hair follicle immune privilege

(2011) Michael Kinori et al.   EXPERIMENTAL DERMATOLOGY

Chronic Migraine: Epidemiology and Disease Burden

(2010) Aubrey N. Manack et al.   Current Pain and Headache Reports

Neurovascular pharmacology of migraine

(2008) Antoinette MaassenVanDenBrink et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Acute and prophylactic treatments for migraine: present and future

(2008) Alan M. Rapoport   NEUROLOGICAL SCIENCES

Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment

(2008) M. E. Bigal et al.   NEUROLOGY